Docetaxel (Taxotere): preclinical and general clinical information.
about
Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)The Tumor Suppressor, p190RhoGAP, Differentially Initiates Apoptosis and Confers Docetaxel Sensitivity to Breast Cancer Cells.Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cellsDocetaxel treatment in the elderly patient with hormone refractory prostate cancer.Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery.
P2860
Docetaxel (Taxotere): preclinical and general clinical information.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Docetaxel (Taxotere): preclinical and general clinical information.
@ast
Docetaxel (Taxotere): preclinical and general clinical information.
@en
type
label
Docetaxel (Taxotere): preclinical and general clinical information.
@ast
Docetaxel (Taxotere): preclinical and general clinical information.
@en
prefLabel
Docetaxel (Taxotere): preclinical and general clinical information.
@ast
Docetaxel (Taxotere): preclinical and general clinical information.
@en
P1433
P1476
Docetaxel (Taxotere): preclinical and general clinical information.
@en
P2093
R H Earhart
P433
5 Suppl 17
P577
1999-10-01T00:00:00Z